Gilead Didn't Pay Teva In HIV Drug IP Deal, Economist Says
By Bonnie Eslinger · June 26, 2023, 9:52 PM EDT
An economics expert for Gilead and Teva, testifying Monday in a federal antitrust trial over claims the pharmaceutical giants struck an illegal "pay for delay" patent deal over two HIV medications,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login